Source: Pharmaceutical Business Review

Clinigen: Essential and Clinigen expand JAPAC partnership to drive patient access

This expansion includes exclusive distribution agreements as well as new market authorisation transfers. The current agreement in Japan follows the last year agreement between the two companies for The post Essential and Clinigen expand JAPAC partnership to drive patient access appeared first on Pharmaceutical Business review.

Read full article »
Est. Annual Revenue
$500M-1.0B
Est. Employees
1.0-5.0K
Jerome Charton's photo - CEO of Clinigen

CEO

Jerome Charton

CEO Approval Rating

82/100

Read more